Cover Image
市場調查報告書

醫療領域的3D列印的全球市場:其作用與市場機會:技術方式 (LBM,EBM,立體光固成型法),材料 (金屬,細胞),用途 (植入,組織工程),各地區市場分析與未來預測

3D Printing in Healthcare Market - By Material (Donor Cells, Plastics, Metals, Ceramics, Bone Cement); By Application (Implants, Tissue Engineering, Surgical Guides, Hearing Aids, Dental Implants, Medical Components) - Forecast (2015 to 2020).

出版商 IndustryARC 商品編碼 351070
出版日期 內容資訊 英文 157 Pages
訂單完成後即時交付
價格
Back to Top
醫療領域的3D列印的全球市場:其作用與市場機會:技術方式 (LBM,EBM,立體光固成型法),材料 (金屬,細胞),用途 (植入,組織工程),各地區市場分析與未來預測 3D Printing in Healthcare Market - By Material (Donor Cells, Plastics, Metals, Ceramics, Bone Cement); By Application (Implants, Tissue Engineering, Surgical Guides, Hearing Aids, Dental Implants, Medical Components) - Forecast (2015 to 2020).
出版日期: 2016年04月14日 內容資訊: 英文 157 Pages
簡介

3D列印技術廣泛用於各種醫療領域,2014年醫療領域的3D列印全球市場規模達到4億8700萬美元。這個市場預計到2020年前將以18.3%的年複合成長率 (CAGR) 持續擴大。

本報告詳查醫療領域的3D列印全球市場,從各種角度總括性檢驗推動市場成長要素,阻礙因素,課題,市場魅力度,市場機會,市場競爭情形,再加上目前市場方案分析與今後的市場預測。

第1章 摘要整理

第2章 醫療領域的3D列印的全球市場 - 市場概要

  • 序論
  • 利害關係者

第3章 市場概況

  • 主要企業分析
  • 比較分析
    • 產品基準

第4章 醫療領域的3D列印市場 - 市場動態

  • 推動市場成長要素
    • 醫療產業上植入需求的增加
    • 伴隨3D列印技術的引進擴大,新加入企業研究開發投資的增加
  • 阻礙市場成長要素
    • 印表機高成本,以及3D列印僅能使用有限的材料
  • 市場課題
    • 新加入企業的永續性
    • 器官植入上的3D列印與藥物合成
  • 醫療領域的3D列印之市場魅力

第5章 醫療領域的3D列印的全球市場 - 策略性分析

  • 價值鏈分析
  • 價格分析
    • 3D列印材料
    • 醫療領域的3D列印
  • 市場機會分析
    • 3D列印材料市場演進
    • 利用3D列印製成器官的革新
  • 市場生命週期分析
  • 提供者及銷售企業分析

第6章 醫療領域的3D列印的全球市場 - 技術方式別分析

  • 雷射電子束溶融 (LBM)
  • 電子束溶融 (EBM)
  • 立體光固成型法
  • 光致聚合
  • 液滴沈積法
  • 薄膜層積法
  • 溶融樹脂層積法
  • 生物印刷

第7章 醫療領域的3D列印的全球市場 - 不同材料分析

  • 捐贈者細胞
  • 塑膠
  • 金屬
  • 陶瓷
  • 骨水泥
  • 其他

第8章 醫療領域的3D列印的全球市場 - 各用途分析

  • 序論
    • 植入及外科手術的增加生出3D列印需求
  • 植入及補綴
  • 手術.指南
  • 助聽器
  • 組織工程
  • 人工植牙
  • 醫療用零件
  • 藥物篩檢

第9章 各地區分析

  • 序論
  • 南北美洲地區
    • 美國
    • 加拿大
    • 巴西
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
  • 其他地區

第10章 主要企業簡介

  • Javelin Technologies Inc.
  • Medical Modeling Inc.
  • Nano3D Biosciences Inc.
  • Tissue Regeneration Systems Inc.
  • Xilloc Medical
  • 3D Biotek Llc.
  • 3T RPD Ltd.
  • Alphaform Ag
  • Organovo Holdings Inc.
  • Beltone A/S
  • Gyrobot Limited
  • Stryker Corporation
  • 3D Systems
  • Stratasys Ltd.
  • Arcam
  • Envisiontec Gmbh
  • EOS GMBH Electro Optical Systems
  • Materialise N.V.
  • Oxford Performance Materials
  • Tethon 3D

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

3D printing has begun to flourish in various application areas in healthcare such as dental, medical, implants, drug manufacturing and so on. The materials used for these purposes vary accordingly. While dental implants mostly use metals and ceramics to print dental crowns, the medical industry has its own array of bio-materials. As per IndustryARC analysis, the 3DP materials in healthcare market has revenue of $284.7 million as of 2014, and is estimated to grow at a CAGR of 19.1% over the next 6 years.

Reduction in prices of printers in healthcare 3D printing is estimated due to the growing demand and possible subsidies from governments as part of research grants as well. The commonly used materials for 3D printing of healthcare are plastics, metals, ceramics, donor cells, bone cement, biomaterials etc. Metal powders and biomaterials are expensive, wherein biomaterials are under research stage and are expected to be a prominent material for the 3D printing in healthcare industry. The global 3D printing in healthcare market recorded revenue of $487m in 2014 and is estimated to grow at a CAGR of 18.3% till 2020. The high growth rate in this market is due to increasing adaptation of 3D printing technologies into healthcare. This increasing adoption is due to wide spectrum of 3D printing applications in healthcare. The market is set to be driven by the increasing demand for patient-specific tailored products in orthopedics and maxillofacial surgery. Advances in tissue engineering for 3D bio-printing is gaining importance and the tissues generated by bio-printing will be available for transplant in the near future. However, high costs and regulatory barriers are likely to hinder the market growth.

North America is the leading consumer of 3D printing in healthcare industry, followed by Europe. Asia-Pacific's (APAC's) market is relatively small as compared to Americas region; however it is growing at a higher rate compared to Americas. With respect to the global market, the US itself holds 39.7% of the entire 3D printing in healthcare market share with existing major players like 3D Systems and Stratasys along with the new entrants and their investments to acquire the growing market. Europe is the second major market followed by APAC, together accounting for around 37% of the global market of 2014. Other factors affecting the growth of the market include technology innovation, efficiency and flexibility of printers and availability of good quality materials.

In this report, the market has been segmented by geography as America, Europe, Asia, and Rest of the World (RoW). Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the 3DP materials, printers, software and scanners market and future opportunities are provided in the report.

Key players covered in the market landscape analysis section are:

Digilab

EnvisionTEC

Invetech

MicroFab Technologies

nScrypt

Tevido BioDevices.

1 Executive Summary

2 Global 3D Printing in Healthcare - Market Overview

  • 2.1 Introduction
  • 2.2 Stakeholders

3 Market Landscape

  • 3.1 Market Player Analysis
  • 3.2 Comparative Analysis
    • 3.2.1 Product Benchmarking
  • 3.3 Patent Analysis
  • 4 3D Printing in Healthcare Market - Market Forces
  • 4.1 Market Drivers
    • 4.1.1 Increasing Demand for Implants in the Health Care Industry
    • 4.1.2 Increased Investments in R&D from New Entrants Due To Growing Adaption of 3D Printing Technology
    • 4.1.3 FDA Approvals to Boost Medical 3D Printing Market Further
  • 4.2 Market Constraints
    • 4.2.1 High Costs of Printers and Reliablity and Wastage of Materials
  • 4.3 Market Challenges
    • 4.3.1 Sustainability of New Entrants
      • 4.3.2 3D Printing of Organ Implants and Drug Synthesis
    • 4.3.3 Limited Build Size of the End Products
    • 4.3.4 Threat of Illicit Manufacturing of Drugs
    • 4.3.5 Regulatory Concerns
  • 4.4 Attractiveness of the 3D Printing in Healthcare
    • 4.4.1 Power of Suppliers
    • 4.4.2 Power of Customers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitution
    • 4.4.5 Degree of Competition

5 Global 3D Printing in Healthcare Market - Strategic Analysis

  • 5.1 Value Chain Analysis
      • 5.1.1 3Dp Materials
      • 5.1.2 3D Printers
  • 5.2 Pricing Analysis
      • 5.2.1 3Dp Materials
      • 5.2.2 3D Printers in Healthcare
  • 5.3 Opportunities Analysis
    • 5.3.1 Evolution in 3D Printing (3Dp) Materials Market
    • 5.3.2 Innovations in 3D Printed Organs
  • 5.4 Market Life Cycle Analysis
  • 5.5 Supplier and Distributor Analysis

6 Global 3D Printing in Healthcare Market - by Technology

  • 6.1 Introduction
  • 6.2 Laser Beam Melting (LBM)
  • 6.3 Electron Beam Melting (EBM)
  • 6.4 Stereo Lithography
  • 6.5 Photo Polymerization
  • 6.6 Droplet Deposition
  • 6.7 Laminated Object Manufacturing
  • 6.8 Wax Deposition Modeling
  • 6.9 Bio Printing

7 Global 3D Printing in Healthcare Market - by Material

  • 7.1 Donor Cells
  • 7.2 Plastics/Polymers
  • 7.3 Photopolymers:
  • 7.4 Metals
  • 7.5 Ceramics
  • 7.6 Bone Cement
  • 7.7 Others

8 Global 3D Printing in Healthcare Market - by Application

  • 8.1 Introduction
    • 8.1.1 Rising Implants and Surgeries Create Demand for 3D Printing
  • 8.2 Implants
  • 8.3 Prosthetics
  • 8.4 Surgical Guides
  • 8.5 Dental Implants
  • 8.6 Medical Components
  • 8.7 Hearing Aids
  • 8.8 Tissue Engineering
  • 8.9 Drug Screening

9 By Geography

  • 9.1 Introduction
  • 9.2 Americas
    • 9.2.1 U.S
    • 9.2.2 Canada
    • 9.2.3 Brazil
  • 9.3 Europe
    • 9.3.1 U.K
    • 9.3.2 Germany
    • 9.3.3 France
    • 9.3.4 Others
  • 9.4 Asia-Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 Australia
    • 9.4.4 Others
  • 9.5 Rest of World

10 Company Profiles

  • 10.1 Javelin Technologies Inc.
    • 10.1.1 Business Overview
    • 10.1.2 Financials
    • 10.1.3 Products
    • 10.1.4 Developments
  • 10.2 Medical Modeling Inc.
    • 10.2.1 Business Overview
    • 10.2.2 Financials
    • 10.2.3 Products & Services
    • 10.2.4 Developments
  • 10.3 Nano3D Biosciences Inc.
    • 10.3.1 Business Overview
    • 10.3.2 Financials
    • 10.3.3 Products & Services
    • 10.3.4 Developments
  • 10.4 Tissue Regeneration Systems Inc.
    • 10.4.1 Business Overview
    • 10.4.2 Financials
    • 10.4.3 Products
    • 10.4.4 Developments
  • 10.5 XILLOC Medical
    • 10.5.1 Business Overview
    • 10.5.2 Financials
    • 10.5.3 Products
    • 10.5.4 Developments
    • 10.6 3D Biotek LLC.
    • 10.6.1 Overview
    • 10.6.2 Financials
    • 10.6.3 Products
    • 10.6.4 Development
    • 10.7 3T RPD Ltd.
    • 10.7.1 Overview
    • 10.7.2 Products
    • 10.7.3 Developments
  • 10.8 Alphaform AG
    • 10.8.1 Overview
    • 10.8.2 Financials
    • 10.8.3 Products
    • 10.8.4 Developments
  • 10.9 Organovo Holdings Inc.
    • 10.9.1 Overview
    • 10.9.2 Financials
    • 10.9.3 Products and Services
    • 10.9.4 Developments
  • 10.10 Beltone A/S
    • 10.10.1 Business Overview
    • 10.10.2 Financials
    • 10.10.3 Products
    • 10.10.4 Developments
  • 10.11 Gyrobot Limited
    • 10.11.1 Business Overview
    • 10.11.2 Financials
    • 10.11.3 Products
    • 10.11.4 Developments
  • 10.12 Stryker Corporation
    • 10.12.1 Business Overview
    • 10.12.2 Financials
    • 10.12.3 Products
    • 10.12.4 Developments
    • 10.13 3D Systems
    • 10.13.1 Business Overview
    • 10.13.2 Financials
    • 10.13.3 Products
    • 10.13.4 Strategy
    • 10.13.5 Developments
  • 10.14 Stratasys Ltd.
    • 10.14.1 Business Overview
    • 10.14.2 Financials
    • 10.14.3 Products
    • 10.14.4 Strategy
    • 10.14.5 Developments
  • 10.15 ARCAM AB
    • 10.15.1 Business Overview
    • 10.15.2 Financials
    • 10.15.3 Products
    • 10.15.4 Strategy
    • 10.15.5 Developments
  • 10.16 ENVISIONTEC GMBH
    • 10.16.1 Business Overview
    • 10.16.2 Financials
    • 10.16.3 Products
    • 10.16.4 Strategy
    • 10.16.5 Developments
  • 10.17 EOS GMBH
    • 10.17.1 Business Overview
    • 10.17.2 Financials
    • 10.17.3 Products
    • 10.17.4 Strategy
    • 10.17.5 Developments
  • 10.18 Materialise N.V.
    • 10.18.1 Business Overview
    • 10.18.2 Financials
    • 10.18.3 Products
    • 10.18.4 Strategy
    • 10.18.5 Developments
  • 10.19 Oxford Performance Materials
    • 10.19.1 Business Overview
    • 10.19.2 Financials
    • 10.19.3 Products
    • 10.19.4 Strategy
    • 10.19.5 Developments
  • 10.20 Tethon 3D
    • 10.20.1 Business Overview
    • 10.20.2 Financials
    • 10.20.3 Products
    • 10.20.4 Strategy
    • 10.20.5 Developments

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

Back to Top